Chehade, C. H., Jo, Y., Ozay, Z. I., Ostrowski, M., Sayegh, N., Gebrael, G., Hardy, R., Lin, E., Ji, R., Chigarira, B., Nussenzveig, R. H., Srivastava, A., Thomas, V. M., Gupta, S., Maughan, B. L., Agarwal, N., Swami, U. (2025). Utilization and timing of first tumor next-generation sequencing testing (NGS) in patients (pts) with five most common cancers in the USA.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.11014